nodes	percent_of_prediction	percent_of_DWPC	metapath
Famotidine—Histamine H2 Receptor Antagonists—Cimetidine—obesity	0.678	1	CiPCiCtD
Famotidine—SLC47A1—Cimetidine—obesity	0.0891	0.4	CbGbCtD
Famotidine—HRH2—Cimetidine—obesity	0.0674	0.303	CbGbCtD
Famotidine—SLC22A2—Cimetidine—obesity	0.0276	0.124	CbGbCtD
Famotidine—SLC22A8—Cimetidine—obesity	0.0236	0.106	CbGbCtD
Famotidine—CYP2C19—Cimetidine—obesity	0.00909	0.0408	CbGbCtD
Famotidine—CYP2C19—Topiramate—obesity	0.00595	0.0267	CbGbCtD
Famotidine—SLC47A1—hindbrain—obesity	0.000361	0.139	CbGeAlD
Famotidine—HRH2—cardiovascular system—obesity	0.000219	0.0843	CbGeAlD
Famotidine—SLC47A1—adrenal cortex—obesity	0.000185	0.0713	CbGeAlD
Famotidine—HRH2—digestive system—obesity	0.000182	0.07	CbGeAlD
Famotidine—HRH2—adrenal gland—obesity	0.000173	0.0667	CbGeAlD
Famotidine—SLC22A2—digestive system—obesity	0.000166	0.0638	CbGeAlD
Famotidine—HRH2—endocrine gland—obesity	0.00015	0.0578	CbGeAlD
Famotidine—SLC47A1—pituitary gland—obesity	0.00015	0.0576	CbGeAlD
Famotidine—SLC47A1—adipose tissue—obesity	0.000149	0.0574	CbGeAlD
Famotidine—SLC47A1—digestive system—obesity	0.00014	0.054	CbGeAlD
Famotidine—HRH2—liver—obesity	0.000135	0.0521	CbGeAlD
Famotidine—SLC47A1—adrenal gland—obesity	0.000134	0.0515	CbGeAlD
Famotidine—SLC47A1—endocrine gland—obesity	0.000116	0.0446	CbGeAlD
Famotidine—Erectile dysfunction—Bupropion—obesity	0.000109	0.00172	CcSEcCtD
Famotidine—Nausea—Phenylpropanolamine—obesity	0.000109	0.00171	CcSEcCtD
Famotidine—Photosensitivity reaction—Bupropion—obesity	0.000108	0.0017	CcSEcCtD
Famotidine—Pharyngitis—Sibutramine—obesity	0.000108	0.0017	CcSEcCtD
Famotidine—Hypersensitivity—Cimetidine—obesity	0.000107	0.00168	CcSEcCtD
Famotidine—Stevens-Johnson syndrome—Bupropion—obesity	0.000105	0.00165	CcSEcCtD
Famotidine—SLC47A1—liver—obesity	0.000105	0.0402	CbGeAlD
Famotidine—Diarrhoea—Diethylpropion—obesity	0.000104	0.00164	CcSEcCtD
Famotidine—Nausea—Phentermine—obesity	0.000104	0.00164	CcSEcCtD
Famotidine—Asthenia—Cimetidine—obesity	0.000104	0.00164	CcSEcCtD
Famotidine—Jaundice—Bupropion—obesity	0.000103	0.00162	CcSEcCtD
Famotidine—Ear pain—Topiramate—obesity	0.000103	0.00161	CcSEcCtD
Famotidine—Tinnitus—Sibutramine—obesity	0.000102	0.0016	CcSEcCtD
Famotidine—Dizziness—Diethylpropion—obesity	0.000101	0.00158	CcSEcCtD
Famotidine—Alopecia—Orlistat—obesity	9.95e-05	0.00157	CcSEcCtD
Famotidine—Sinusitis—Bupropion—obesity	9.93e-05	0.00156	CcSEcCtD
Famotidine—Diarrhoea—Cimetidine—obesity	9.92e-05	0.00156	CcSEcCtD
Famotidine—Mental disorder—Orlistat—obesity	9.87e-05	0.00155	CcSEcCtD
Famotidine—Disorientation—Topiramate—obesity	9.78e-05	0.00154	CcSEcCtD
Famotidine—Arrhythmia—Sibutramine—obesity	9.74e-05	0.00153	CcSEcCtD
Famotidine—Vomiting—Diethylpropion—obesity	9.68e-05	0.00152	CcSEcCtD
Famotidine—Alopecia—Sibutramine—obesity	9.63e-05	0.00151	CcSEcCtD
Famotidine—Nasal congestion—Topiramate—obesity	9.61e-05	0.00151	CcSEcCtD
Famotidine—Rash—Diethylpropion—obesity	9.6e-05	0.00151	CcSEcCtD
Famotidine—Dysgeusia—Orlistat—obesity	9.6e-05	0.00151	CcSEcCtD
Famotidine—Dermatitis—Diethylpropion—obesity	9.59e-05	0.00151	CcSEcCtD
Famotidine—Dizziness—Cimetidine—obesity	9.58e-05	0.00151	CcSEcCtD
Famotidine—Headache—Diethylpropion—obesity	9.54e-05	0.0015	CcSEcCtD
Famotidine—Hepatitis—Bupropion—obesity	9.5e-05	0.00149	CcSEcCtD
Famotidine—Back pain—Orlistat—obesity	9.48e-05	0.00149	CcSEcCtD
Famotidine—Hallucination—Bupropion—obesity	9.45e-05	0.00149	CcSEcCtD
Famotidine—Libido decreased—Topiramate—obesity	9.44e-05	0.00148	CcSEcCtD
Famotidine—Pharyngitis—Bupropion—obesity	9.43e-05	0.00148	CcSEcCtD
Famotidine—Muscle spasms—Orlistat—obesity	9.43e-05	0.00148	CcSEcCtD
Famotidine—Dysgeusia—Sibutramine—obesity	9.29e-05	0.00146	CcSEcCtD
Famotidine—Vomiting—Cimetidine—obesity	9.21e-05	0.00145	CcSEcCtD
Famotidine—Back pain—Sibutramine—obesity	9.18e-05	0.00144	CcSEcCtD
Famotidine—Rash—Cimetidine—obesity	9.14e-05	0.00144	CcSEcCtD
Famotidine—Dermatitis—Cimetidine—obesity	9.13e-05	0.00144	CcSEcCtD
Famotidine—Muscle spasms—Sibutramine—obesity	9.12e-05	0.00143	CcSEcCtD
Famotidine—Headache—Cimetidine—obesity	9.08e-05	0.00143	CcSEcCtD
Famotidine—Nausea—Diethylpropion—obesity	9.05e-05	0.00142	CcSEcCtD
Famotidine—CYP2C19—digestive system—obesity	9.02e-05	0.0347	CbGeAlD
Famotidine—Erythema multiforme—Bupropion—obesity	8.98e-05	0.00141	CcSEcCtD
Famotidine—Angioedema—Orlistat—obesity	8.96e-05	0.00141	CcSEcCtD
Famotidine—Tinnitus—Bupropion—obesity	8.86e-05	0.00139	CcSEcCtD
Famotidine—Flushing—Bupropion—obesity	8.82e-05	0.00139	CcSEcCtD
Famotidine—Anaemia—Sibutramine—obesity	8.77e-05	0.00138	CcSEcCtD
Famotidine—Pain in extremity—Topiramate—obesity	8.75e-05	0.00138	CcSEcCtD
Famotidine—Agitation—Sibutramine—obesity	8.72e-05	0.00137	CcSEcCtD
Famotidine—Disturbance in sexual arousal—Topiramate—obesity	8.68e-05	0.00137	CcSEcCtD
Famotidine—Angioedema—Sibutramine—obesity	8.67e-05	0.00136	CcSEcCtD
Famotidine—Palpitations—Orlistat—obesity	8.66e-05	0.00136	CcSEcCtD
Famotidine—Migraine—Topiramate—obesity	8.61e-05	0.00135	CcSEcCtD
Famotidine—Nausea—Cimetidine—obesity	8.61e-05	0.00135	CcSEcCtD
Famotidine—Cough—Orlistat—obesity	8.56e-05	0.00135	CcSEcCtD
Famotidine—Psychotic disorder—Topiramate—obesity	8.55e-05	0.00134	CcSEcCtD
Famotidine—Syncope—Sibutramine—obesity	8.51e-05	0.00134	CcSEcCtD
Famotidine—Convulsion—Orlistat—obesity	8.49e-05	0.00134	CcSEcCtD
Famotidine—Leukopenia—Sibutramine—obesity	8.49e-05	0.00134	CcSEcCtD
Famotidine—Arrhythmia—Bupropion—obesity	8.49e-05	0.00134	CcSEcCtD
Famotidine—Face oedema—Topiramate—obesity	8.45e-05	0.00133	CcSEcCtD
Famotidine—Alopecia—Bupropion—obesity	8.4e-05	0.00132	CcSEcCtD
Famotidine—Palpitations—Sibutramine—obesity	8.38e-05	0.00132	CcSEcCtD
Famotidine—Irritability—Topiramate—obesity	8.35e-05	0.00131	CcSEcCtD
Famotidine—Myalgia—Orlistat—obesity	8.35e-05	0.00131	CcSEcCtD
Famotidine—Chest pain—Orlistat—obesity	8.35e-05	0.00131	CcSEcCtD
Famotidine—Loss of consciousness—Sibutramine—obesity	8.34e-05	0.00131	CcSEcCtD
Famotidine—Mental disorder—Bupropion—obesity	8.32e-05	0.00131	CcSEcCtD
Famotidine—Anxiety—Orlistat—obesity	8.32e-05	0.00131	CcSEcCtD
Famotidine—Cough—Sibutramine—obesity	8.28e-05	0.0013	CcSEcCtD
Famotidine—Convulsion—Sibutramine—obesity	8.22e-05	0.00129	CcSEcCtD
Famotidine—Dry mouth—Orlistat—obesity	8.16e-05	0.00128	CcSEcCtD
Famotidine—Dysgeusia—Bupropion—obesity	8.1e-05	0.00127	CcSEcCtD
Famotidine—Myalgia—Sibutramine—obesity	8.08e-05	0.00127	CcSEcCtD
Famotidine—Arthralgia—Sibutramine—obesity	8.08e-05	0.00127	CcSEcCtD
Famotidine—Chest pain—Sibutramine—obesity	8.08e-05	0.00127	CcSEcCtD
Famotidine—Anxiety—Sibutramine—obesity	8.05e-05	0.00127	CcSEcCtD
Famotidine—Anaphylactic shock—Orlistat—obesity	8e-05	0.00126	CcSEcCtD
Famotidine—Oedema—Orlistat—obesity	8e-05	0.00126	CcSEcCtD
Famotidine—Back pain—Bupropion—obesity	8e-05	0.00126	CcSEcCtD
Famotidine—Muscle spasms—Bupropion—obesity	7.95e-05	0.00125	CcSEcCtD
Famotidine—Infection—Orlistat—obesity	7.95e-05	0.00125	CcSEcCtD
Famotidine—Dry mouth—Sibutramine—obesity	7.9e-05	0.00124	CcSEcCtD
Famotidine—Toxic epidermal necrolysis—Topiramate—obesity	7.88e-05	0.00124	CcSEcCtD
Famotidine—Aspartate aminotransferase increased—Topiramate—obesity	7.88e-05	0.00124	CcSEcCtD
Famotidine—Confusional state—Sibutramine—obesity	7.81e-05	0.00123	CcSEcCtD
Famotidine—Oedema—Sibutramine—obesity	7.74e-05	0.00122	CcSEcCtD
Famotidine—Anaphylactic shock—Sibutramine—obesity	7.74e-05	0.00122	CcSEcCtD
Famotidine—Infection—Sibutramine—obesity	7.69e-05	0.00121	CcSEcCtD
Famotidine—Anaemia—Bupropion—obesity	7.65e-05	0.0012	CcSEcCtD
Famotidine—Shock—Sibutramine—obesity	7.62e-05	0.0012	CcSEcCtD
Famotidine—Agitation—Bupropion—obesity	7.6e-05	0.0012	CcSEcCtD
Famotidine—Thrombocytopenia—Sibutramine—obesity	7.58e-05	0.00119	CcSEcCtD
Famotidine—Angioedema—Bupropion—obesity	7.56e-05	0.00119	CcSEcCtD
Famotidine—CYP2C19—endocrine gland—obesity	7.45e-05	0.0287	CbGeAlD
Famotidine—Syncope—Bupropion—obesity	7.42e-05	0.00117	CcSEcCtD
Famotidine—Leukopenia—Bupropion—obesity	7.4e-05	0.00116	CcSEcCtD
Famotidine—Anorexia—Sibutramine—obesity	7.38e-05	0.00116	CcSEcCtD
Famotidine—Palpitations—Bupropion—obesity	7.31e-05	0.00115	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Orlistat—obesity	7.29e-05	0.00115	CcSEcCtD
Famotidine—Bronchitis—Topiramate—obesity	7.27e-05	0.00114	CcSEcCtD
Famotidine—Loss of consciousness—Bupropion—obesity	7.27e-05	0.00114	CcSEcCtD
Famotidine—Abdominal discomfort—Topiramate—obesity	7.25e-05	0.00114	CcSEcCtD
Famotidine—Insomnia—Orlistat—obesity	7.24e-05	0.00114	CcSEcCtD
Famotidine—Cough—Bupropion—obesity	7.22e-05	0.00114	CcSEcCtD
Famotidine—Paraesthesia—Orlistat—obesity	7.18e-05	0.00113	CcSEcCtD
Famotidine—Pancytopenia—Topiramate—obesity	7.18e-05	0.00113	CcSEcCtD
Famotidine—Convulsion—Bupropion—obesity	7.17e-05	0.00113	CcSEcCtD
Famotidine—Dysuria—Topiramate—obesity	7.07e-05	0.00111	CcSEcCtD
Famotidine—Neutropenia—Topiramate—obesity	7.07e-05	0.00111	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Sibutramine—obesity	7.05e-05	0.00111	CcSEcCtD
Famotidine—Dyspepsia—Orlistat—obesity	7.04e-05	0.00111	CcSEcCtD
Famotidine—Myalgia—Bupropion—obesity	7.04e-05	0.00111	CcSEcCtD
Famotidine—Chest pain—Bupropion—obesity	7.04e-05	0.00111	CcSEcCtD
Famotidine—Arthralgia—Bupropion—obesity	7.04e-05	0.00111	CcSEcCtD
Famotidine—Upper respiratory tract infection—Topiramate—obesity	7.03e-05	0.00111	CcSEcCtD
Famotidine—Anxiety—Bupropion—obesity	7.02e-05	0.0011	CcSEcCtD
Famotidine—Insomnia—Sibutramine—obesity	7e-05	0.0011	CcSEcCtD
Famotidine—Pollakiuria—Topiramate—obesity	6.99e-05	0.0011	CcSEcCtD
Famotidine—Erectile dysfunction—Topiramate—obesity	6.97e-05	0.0011	CcSEcCtD
Famotidine—Decreased appetite—Orlistat—obesity	6.96e-05	0.00109	CcSEcCtD
Famotidine—Paraesthesia—Sibutramine—obesity	6.95e-05	0.00109	CcSEcCtD
Famotidine—Photosensitivity reaction—Topiramate—obesity	6.9e-05	0.00109	CcSEcCtD
Famotidine—Fatigue—Orlistat—obesity	6.9e-05	0.00109	CcSEcCtD
Famotidine—Dry mouth—Bupropion—obesity	6.89e-05	0.00108	CcSEcCtD
Famotidine—Somnolence—Sibutramine—obesity	6.88e-05	0.00108	CcSEcCtD
Famotidine—Pain—Orlistat—obesity	6.84e-05	0.00108	CcSEcCtD
Famotidine—Dyspepsia—Sibutramine—obesity	6.82e-05	0.00107	CcSEcCtD
Famotidine—Confusional state—Bupropion—obesity	6.81e-05	0.00107	CcSEcCtD
Famotidine—Oedema—Bupropion—obesity	6.75e-05	0.00106	CcSEcCtD
Famotidine—Anaphylactic shock—Bupropion—obesity	6.75e-05	0.00106	CcSEcCtD
Famotidine—Decreased appetite—Sibutramine—obesity	6.73e-05	0.00106	CcSEcCtD
Famotidine—Depression—Topiramate—obesity	6.72e-05	0.00106	CcSEcCtD
Famotidine—CYP2C19—liver—obesity	6.72e-05	0.0259	CbGeAlD
Famotidine—Infection—Bupropion—obesity	6.71e-05	0.00105	CcSEcCtD
Famotidine—Stevens-Johnson syndrome—Topiramate—obesity	6.69e-05	0.00105	CcSEcCtD
Famotidine—Shock—Bupropion—obesity	6.64e-05	0.00104	CcSEcCtD
Famotidine—Pain—Sibutramine—obesity	6.62e-05	0.00104	CcSEcCtD
Famotidine—Constipation—Sibutramine—obesity	6.62e-05	0.00104	CcSEcCtD
Famotidine—Thrombocytopenia—Bupropion—obesity	6.61e-05	0.00104	CcSEcCtD
Famotidine—Feeling abnormal—Orlistat—obesity	6.59e-05	0.00104	CcSEcCtD
Famotidine—Gastrointestinal pain—Orlistat—obesity	6.54e-05	0.00103	CcSEcCtD
Famotidine—Anorexia—Bupropion—obesity	6.43e-05	0.00101	CcSEcCtD
Famotidine—Haematuria—Topiramate—obesity	6.43e-05	0.00101	CcSEcCtD
Famotidine—Feeling abnormal—Sibutramine—obesity	6.38e-05	0.001	CcSEcCtD
Famotidine—Urticaria—Orlistat—obesity	6.36e-05	0.001	CcSEcCtD
Famotidine—Gastrointestinal pain—Sibutramine—obesity	6.33e-05	0.000996	CcSEcCtD
Famotidine—Sinusitis—Topiramate—obesity	6.33e-05	0.000995	CcSEcCtD
Famotidine—Abdominal pain—Orlistat—obesity	6.33e-05	0.000995	CcSEcCtD
Famotidine—Body temperature increased—Orlistat—obesity	6.33e-05	0.000995	CcSEcCtD
Famotidine—Agranulocytosis—Topiramate—obesity	6.29e-05	0.00099	CcSEcCtD
Famotidine—Bradycardia—Topiramate—obesity	6.16e-05	0.000969	CcSEcCtD
Famotidine—Urticaria—Sibutramine—obesity	6.15e-05	0.000968	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Bupropion—obesity	6.15e-05	0.000967	CcSEcCtD
Famotidine—Abdominal pain—Sibutramine—obesity	6.12e-05	0.000963	CcSEcCtD
Famotidine—Body temperature increased—Sibutramine—obesity	6.12e-05	0.000963	CcSEcCtD
Famotidine—Insomnia—Bupropion—obesity	6.11e-05	0.00096	CcSEcCtD
Famotidine—Paraesthesia—Bupropion—obesity	6.06e-05	0.000953	CcSEcCtD
Famotidine—Hepatitis—Topiramate—obesity	6.05e-05	0.000952	CcSEcCtD
Famotidine—Hallucination—Topiramate—obesity	6.02e-05	0.000947	CcSEcCtD
Famotidine—Pharyngitis—Topiramate—obesity	6.01e-05	0.000945	CcSEcCtD
Famotidine—Somnolence—Bupropion—obesity	6e-05	0.000944	CcSEcCtD
Famotidine—Dyspepsia—Bupropion—obesity	5.94e-05	0.000935	CcSEcCtD
Famotidine—Hypersensitivity—Orlistat—obesity	5.89e-05	0.000927	CcSEcCtD
Famotidine—Decreased appetite—Bupropion—obesity	5.87e-05	0.000923	CcSEcCtD
Famotidine—Fatigue—Bupropion—obesity	5.82e-05	0.000915	CcSEcCtD
Famotidine—Constipation—Bupropion—obesity	5.77e-05	0.000908	CcSEcCtD
Famotidine—Pain—Bupropion—obesity	5.77e-05	0.000908	CcSEcCtD
Famotidine—Asthenia—Orlistat—obesity	5.74e-05	0.000903	CcSEcCtD
Famotidine—Erythema multiforme—Topiramate—obesity	5.72e-05	0.0009	CcSEcCtD
Famotidine—Hypersensitivity—Sibutramine—obesity	5.71e-05	0.000897	CcSEcCtD
Famotidine—Pruritus—Orlistat—obesity	5.66e-05	0.00089	CcSEcCtD
Famotidine—Tinnitus—Topiramate—obesity	5.64e-05	0.000888	CcSEcCtD
Famotidine—Flushing—Topiramate—obesity	5.62e-05	0.000884	CcSEcCtD
Famotidine—Feeling abnormal—Bupropion—obesity	5.56e-05	0.000875	CcSEcCtD
Famotidine—Asthenia—Sibutramine—obesity	5.56e-05	0.000874	CcSEcCtD
Famotidine—Gastrointestinal pain—Bupropion—obesity	5.52e-05	0.000868	CcSEcCtD
Famotidine—Pruritus—Sibutramine—obesity	5.48e-05	0.000862	CcSEcCtD
Famotidine—Diarrhoea—Orlistat—obesity	5.47e-05	0.000861	CcSEcCtD
Famotidine—Urticaria—Bupropion—obesity	5.36e-05	0.000844	CcSEcCtD
Famotidine—Alopecia—Topiramate—obesity	5.35e-05	0.000841	CcSEcCtD
Famotidine—Abdominal pain—Bupropion—obesity	5.34e-05	0.000839	CcSEcCtD
Famotidine—Body temperature increased—Bupropion—obesity	5.34e-05	0.000839	CcSEcCtD
Famotidine—Mental disorder—Topiramate—obesity	5.3e-05	0.000834	CcSEcCtD
Famotidine—Diarrhoea—Sibutramine—obesity	5.3e-05	0.000833	CcSEcCtD
Famotidine—Dizziness—Orlistat—obesity	5.29e-05	0.000832	CcSEcCtD
Famotidine—Dysgeusia—Topiramate—obesity	5.16e-05	0.000812	CcSEcCtD
Famotidine—Dizziness—Sibutramine—obesity	5.12e-05	0.000805	CcSEcCtD
Famotidine—Back pain—Topiramate—obesity	5.1e-05	0.000802	CcSEcCtD
Famotidine—Vomiting—Orlistat—obesity	5.09e-05	0.0008	CcSEcCtD
Famotidine—Muscle spasms—Topiramate—obesity	5.07e-05	0.000797	CcSEcCtD
Famotidine—Rash—Orlistat—obesity	5.04e-05	0.000794	CcSEcCtD
Famotidine—Dermatitis—Orlistat—obesity	5.04e-05	0.000793	CcSEcCtD
Famotidine—Headache—Orlistat—obesity	5.01e-05	0.000788	CcSEcCtD
Famotidine—Hypersensitivity—Bupropion—obesity	4.97e-05	0.000782	CcSEcCtD
Famotidine—Vomiting—Sibutramine—obesity	4.92e-05	0.000774	CcSEcCtD
Famotidine—Rash—Sibutramine—obesity	4.88e-05	0.000768	CcSEcCtD
Famotidine—Dermatitis—Sibutramine—obesity	4.88e-05	0.000767	CcSEcCtD
Famotidine—Anaemia—Topiramate—obesity	4.87e-05	0.000766	CcSEcCtD
Famotidine—Headache—Sibutramine—obesity	4.85e-05	0.000763	CcSEcCtD
Famotidine—Asthenia—Bupropion—obesity	4.84e-05	0.000762	CcSEcCtD
Famotidine—Agitation—Topiramate—obesity	4.84e-05	0.000762	CcSEcCtD
Famotidine—Pruritus—Bupropion—obesity	4.78e-05	0.000751	CcSEcCtD
Famotidine—Nausea—Orlistat—obesity	4.75e-05	0.000748	CcSEcCtD
Famotidine—Syncope—Topiramate—obesity	4.73e-05	0.000743	CcSEcCtD
Famotidine—Leukopenia—Topiramate—obesity	4.72e-05	0.000742	CcSEcCtD
Famotidine—Palpitations—Topiramate—obesity	4.66e-05	0.000732	CcSEcCtD
Famotidine—Loss of consciousness—Topiramate—obesity	4.63e-05	0.000729	CcSEcCtD
Famotidine—Diarrhoea—Bupropion—obesity	4.62e-05	0.000727	CcSEcCtD
Famotidine—Nausea—Sibutramine—obesity	4.6e-05	0.000723	CcSEcCtD
Famotidine—Cough—Topiramate—obesity	4.6e-05	0.000723	CcSEcCtD
Famotidine—Convulsion—Topiramate—obesity	4.57e-05	0.000718	CcSEcCtD
Famotidine—Chest pain—Topiramate—obesity	4.49e-05	0.000706	CcSEcCtD
Famotidine—Myalgia—Topiramate—obesity	4.49e-05	0.000706	CcSEcCtD
Famotidine—Arthralgia—Topiramate—obesity	4.49e-05	0.000706	CcSEcCtD
Famotidine—Anxiety—Topiramate—obesity	4.47e-05	0.000703	CcSEcCtD
Famotidine—Dizziness—Bupropion—obesity	4.46e-05	0.000702	CcSEcCtD
Famotidine—Dry mouth—Topiramate—obesity	4.39e-05	0.00069	CcSEcCtD
Famotidine—Confusional state—Topiramate—obesity	4.34e-05	0.000682	CcSEcCtD
Famotidine—Oedema—Topiramate—obesity	4.3e-05	0.000676	CcSEcCtD
Famotidine—Vomiting—Bupropion—obesity	4.29e-05	0.000675	CcSEcCtD
Famotidine—Infection—Topiramate—obesity	4.27e-05	0.000672	CcSEcCtD
Famotidine—Rash—Bupropion—obesity	4.26e-05	0.000669	CcSEcCtD
Famotidine—Dermatitis—Bupropion—obesity	4.25e-05	0.000669	CcSEcCtD
Famotidine—Shock—Topiramate—obesity	4.23e-05	0.000666	CcSEcCtD
Famotidine—Headache—Bupropion—obesity	4.23e-05	0.000665	CcSEcCtD
Famotidine—Thrombocytopenia—Topiramate—obesity	4.21e-05	0.000662	CcSEcCtD
Famotidine—Anorexia—Topiramate—obesity	4.1e-05	0.000645	CcSEcCtD
Famotidine—Nausea—Bupropion—obesity	4.01e-05	0.000631	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Topiramate—obesity	3.92e-05	0.000616	CcSEcCtD
Famotidine—Insomnia—Topiramate—obesity	3.89e-05	0.000612	CcSEcCtD
Famotidine—Paraesthesia—Topiramate—obesity	3.86e-05	0.000607	CcSEcCtD
Famotidine—Somnolence—Topiramate—obesity	3.82e-05	0.000601	CcSEcCtD
Famotidine—Dyspepsia—Topiramate—obesity	3.79e-05	0.000595	CcSEcCtD
Famotidine—Decreased appetite—Topiramate—obesity	3.74e-05	0.000588	CcSEcCtD
Famotidine—Fatigue—Topiramate—obesity	3.71e-05	0.000583	CcSEcCtD
Famotidine—Pain—Topiramate—obesity	3.68e-05	0.000578	CcSEcCtD
Famotidine—Constipation—Topiramate—obesity	3.68e-05	0.000578	CcSEcCtD
Famotidine—Feeling abnormal—Topiramate—obesity	3.54e-05	0.000557	CcSEcCtD
Famotidine—Gastrointestinal pain—Topiramate—obesity	3.52e-05	0.000553	CcSEcCtD
Famotidine—Urticaria—Topiramate—obesity	3.42e-05	0.000537	CcSEcCtD
Famotidine—Abdominal pain—Topiramate—obesity	3.4e-05	0.000535	CcSEcCtD
Famotidine—Body temperature increased—Topiramate—obesity	3.4e-05	0.000535	CcSEcCtD
Famotidine—Hypersensitivity—Topiramate—obesity	3.17e-05	0.000498	CcSEcCtD
Famotidine—Asthenia—Topiramate—obesity	3.09e-05	0.000485	CcSEcCtD
Famotidine—Pruritus—Topiramate—obesity	3.04e-05	0.000479	CcSEcCtD
Famotidine—Diarrhoea—Topiramate—obesity	2.94e-05	0.000463	CcSEcCtD
Famotidine—Dizziness—Topiramate—obesity	2.84e-05	0.000447	CcSEcCtD
Famotidine—Vomiting—Topiramate—obesity	2.73e-05	0.00043	CcSEcCtD
Famotidine—Rash—Topiramate—obesity	2.71e-05	0.000427	CcSEcCtD
Famotidine—Dermatitis—Topiramate—obesity	2.71e-05	0.000426	CcSEcCtD
Famotidine—Headache—Topiramate—obesity	2.69e-05	0.000424	CcSEcCtD
Famotidine—Nausea—Topiramate—obesity	2.55e-05	0.000402	CcSEcCtD
Famotidine—SLC22A2—Metabolism—SLC22A1—obesity	6.68e-06	0.000199	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—PPARA—obesity	6.68e-06	0.000199	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ACLY—obesity	6.57e-06	0.000196	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—SREBF1—obesity	6.54e-06	0.000195	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—SULT2A1—obesity	6.51e-06	0.000194	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GLP1R—obesity	6.51e-06	0.000194	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—PIK3CD—obesity	6.5e-06	0.000194	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—DPYD—obesity	6.41e-06	0.000191	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—POMC—obesity	6.39e-06	0.000191	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PRL—obesity	6.37e-06	0.00019	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ENPP1—obesity	6.35e-06	0.000189	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ALOX12—obesity	6.35e-06	0.000189	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—STK11—obesity	6.28e-06	0.000188	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—APOA1—obesity	6.27e-06	0.000187	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—CCL2—obesity	6.25e-06	0.000187	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—FASN—obesity	6.23e-06	0.000186	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PLG—obesity	6.21e-06	0.000185	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—obesity	6.2e-06	0.000185	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—RHOA—obesity	6.2e-06	0.000185	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PRKAR2B—obesity	6.17e-06	0.000184	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—HMGCS1—obesity	6.15e-06	0.000183	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—AKT2—obesity	6.14e-06	0.000183	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—PIK3R1—obesity	6.14e-06	0.000183	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—DCN—obesity	6.12e-06	0.000183	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—FOXO3—obesity	6.06e-06	0.000181	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—ADRB2—obesity	6.05e-06	0.000181	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ACADM—obesity	5.97e-06	0.000178	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PFKFB3—obesity	5.97e-06	0.000178	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PNPLA2—obesity	5.97e-06	0.000178	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PLIN1—obesity	5.97e-06	0.000178	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—SAT1—obesity	5.97e-06	0.000178	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ANGPTL4—obesity	5.97e-06	0.000178	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—SOCS1—obesity	5.96e-06	0.000178	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CPT1A—obesity	5.96e-06	0.000178	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—PIK3CD—obesity	5.9e-06	0.000176	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—SOCS3—obesity	5.88e-06	0.000176	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—NAMPT—obesity	5.84e-06	0.000174	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ACACB—obesity	5.8e-06	0.000173	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—OXCT1—obesity	5.8e-06	0.000173	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CYTB—obesity	5.8e-06	0.000173	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—LIPC—obesity	5.8e-06	0.000173	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GCK—obesity	5.8e-06	0.000173	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—APOC3—obesity	5.77e-06	0.000172	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—GNB3—obesity	5.76e-06	0.000172	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—TYK2—obesity	5.68e-06	0.00017	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—PIK3CB—obesity	5.67e-06	0.000169	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—IGF2—obesity	5.66e-06	0.000169	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PNLIP—obesity	5.66e-06	0.000169	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—SRD5A1—obesity	5.66e-06	0.000169	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—RHOA—obesity	5.63e-06	0.000168	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—GNAS—obesity	5.61e-06	0.000167	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CETP—obesity	5.6e-06	0.000167	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—PIK3R1—obesity	5.57e-06	0.000166	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—SDC1—obesity	5.54e-06	0.000165	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—SDC3—obesity	5.52e-06	0.000165	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—obesity	5.49e-06	0.000164	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—APOB—obesity	5.49e-06	0.000164	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—AKR1C3—obesity	5.45e-06	0.000163	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—NCOA1—obesity	5.41e-06	0.000162	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CYP26B1—obesity	5.4e-06	0.000161	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—HK2—obesity	5.4e-06	0.000161	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—STS—obesity	5.4e-06	0.000161	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CCL5—obesity	5.36e-06	0.00016	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—SCARB1—obesity	5.36e-06	0.00016	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—obesity	5.33e-06	0.000159	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PPARD—obesity	5.28e-06	0.000158	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—LPL—obesity	5.24e-06	0.000157	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—FOXO1—obesity	5.21e-06	0.000155	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—SREBF1—obesity	5.21e-06	0.000155	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—RPS6KB1—obesity	5.2e-06	0.000155	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—SLC27A1—obesity	5.17e-06	0.000154	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—PIK3CB—obesity	5.15e-06	0.000154	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—FABP4—obesity	5.07e-06	0.000151	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GLUL—obesity	5.07e-06	0.000151	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GOT2—obesity	5.06e-06	0.000151	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—ALB—obesity	4.96e-06	0.000148	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—FASN—obesity	4.96e-06	0.000148	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—BCHE—obesity	4.93e-06	0.000147	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1A—obesity	4.89e-06	0.000146	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PRKCD—obesity	4.83e-06	0.000144	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—UCP2—obesity	4.81e-06	0.000144	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—UCP3—obesity	4.81e-06	0.000144	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—HSD11B1—obesity	4.81e-06	0.000144	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ECHS1—obesity	4.81e-06	0.000144	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CYP2E1—obesity	4.76e-06	0.000142	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ADH1B—obesity	4.73e-06	0.000141	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HTR2A—obesity	4.73e-06	0.000141	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—C3—obesity	4.72e-06	0.000141	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—NQO1—obesity	4.71e-06	0.000141	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—APOB—obesity	4.66e-06	0.000139	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PPARGC1B—obesity	4.66e-06	0.000139	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ACSL1—obesity	4.66e-06	0.000139	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GPAM—obesity	4.66e-06	0.000139	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—HADH—obesity	4.52e-06	0.000135	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—FADS1—obesity	4.52e-06	0.000135	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PCK1—obesity	4.52e-06	0.000135	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—SLC2A4—obesity	4.51e-06	0.000135	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GCG—obesity	4.51e-06	0.000135	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—IRS2—obesity	4.49e-06	0.000134	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—AGT—obesity	4.49e-06	0.000134	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CYCS—obesity	4.45e-06	0.000133	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—LPL—obesity	4.45e-06	0.000133	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ACP5—obesity	4.4e-06	0.000131	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—APOE—obesity	4.4e-06	0.000131	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—LEP—obesity	4.4e-06	0.000131	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GGT1—obesity	4.37e-06	0.000131	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GOT1—obesity	4.37e-06	0.000131	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CAV1—obesity	4.35e-06	0.00013	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—APOA1—obesity	4.34e-06	0.00013	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—obesity	4.34e-06	0.00013	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—NCOA1—obesity	4.31e-06	0.000129	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—G6PD—obesity	4.29e-06	0.000128	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—STK11—obesity	4.24e-06	0.000127	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CYP19A1—obesity	4.24e-06	0.000127	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—SREBF2—obesity	4.23e-06	0.000126	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—HK1—obesity	4.23e-06	0.000126	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—CD36—obesity	4.23e-06	0.000126	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—ESR1—obesity	4.2e-06	0.000125	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—F2—obesity	4.14e-06	0.000124	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PRKCB—obesity	4.14e-06	0.000124	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—BAD—obesity	4.1e-06	0.000122	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—LPA—obesity	4.09e-06	0.000122	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—LPIN1—obesity	4e-06	0.000119	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PIK3CG—obesity	3.97e-06	0.000118	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—COMT—obesity	3.95e-06	0.000118	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—obesity	3.93e-06	0.000117	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—IRS1—obesity	3.92e-06	0.000117	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—APOA5—obesity	3.92e-06	0.000117	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GNB3—obesity	3.89e-06	0.000116	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PPARGC1A—obesity	3.89e-06	0.000116	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—HMOX1—obesity	3.87e-06	0.000116	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—obesity	3.81e-06	0.000114	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GNAS—obesity	3.79e-06	0.000113	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—POMC—obesity	3.78e-06	0.000113	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—INS—obesity	3.75e-06	0.000112	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CLOCK—obesity	3.74e-06	0.000112	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—SLC22A1—obesity	3.74e-06	0.000112	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—obesity	3.73e-06	0.000111	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—APOB—obesity	3.71e-06	0.000111	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—obesity	3.7e-06	0.00011	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CCL2—obesity	3.69e-06	0.00011	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—obesity	3.69e-06	0.00011	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—SULT2A1—obesity	3.64e-06	0.000109	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GLP1R—obesity	3.64e-06	0.000109	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—IGF1—obesity	3.63e-06	0.000108	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—AKT2—obesity	3.63e-06	0.000108	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—DPYD—obesity	3.59e-06	0.000107	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—LPL—obesity	3.54e-06	0.000106	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PIK3CD—obesity	3.49e-06	0.000104	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GPX1—obesity	3.46e-06	0.000103	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—PIK3CA—obesity	3.45e-06	0.000103	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PRKAR2B—obesity	3.45e-06	0.000103	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—SERPINE1—obesity	3.45e-06	0.000103	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—DCN—obesity	3.43e-06	0.000102	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—obesity	3.37e-06	0.000101	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CD36—obesity	3.37e-06	0.0001	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—TYK2—obesity	3.35e-06	0.0001	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CPT1A—obesity	3.33e-06	9.95e-05	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—RHOA—obesity	3.33e-06	9.93e-05	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PIK3R1—obesity	3.29e-06	9.83e-05	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NOS3—obesity	3.29e-06	9.83e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—NAMPT—obesity	3.27e-06	9.76e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—obesity	3.25e-06	9.7e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—LIPC—obesity	3.25e-06	9.7e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GCK—obesity	3.25e-06	9.7e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—APOC3—obesity	3.23e-06	9.64e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—obesity	3.21e-06	9.57e-05	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—MTHFR—obesity	3.19e-06	9.52e-05	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—PIK3CA—obesity	3.14e-06	9.36e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CETP—obesity	3.13e-06	9.36e-05	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PPARA—obesity	3.13e-06	9.34e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—SDC1—obesity	3.1e-06	9.25e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—AKR1C3—obesity	3.05e-06	9.1e-05	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MTOR—obesity	3.04e-06	9.07e-05	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PIK3CB—obesity	3.04e-06	9.07e-05	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—AGT—obesity	3.03e-06	9.05e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—SCARB1—obesity	3e-06	8.96e-05	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—APOE—obesity	2.97e-06	8.86e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—obesity	2.96e-06	8.84e-05	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CAV1—obesity	2.94e-06	8.78e-05	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—APOA1—obesity	2.93e-06	8.76e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—obesity	2.92e-06	8.72e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—SREBF1—obesity	2.91e-06	8.7e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GOT2—obesity	2.83e-06	8.46e-05	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—AKT1—obesity	2.82e-06	8.42e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—obesity	2.8e-06	8.35e-05	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—IL6—obesity	2.78e-06	8.29e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—FASN—obesity	2.77e-06	8.28e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—BCHE—obesity	2.76e-06	8.25e-05	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PIK3CG—obesity	2.68e-06	8e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CYP2E1—obesity	2.66e-06	7.96e-05	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MMP9—obesity	2.64e-06	7.89e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—NQO1—obesity	2.63e-06	7.87e-05	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PPARG—obesity	2.59e-06	7.72e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—obesity	2.58e-06	7.7e-05	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MAPK8—obesity	2.57e-06	7.67e-05	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—AKT1—obesity	2.56e-06	7.65e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—obesity	2.56e-06	7.63e-05	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—POMC—obesity	2.55e-06	7.61e-05	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—INS—obesity	2.54e-06	7.57e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GCG—obesity	2.53e-06	7.54e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—SLC2A4—obesity	2.53e-06	7.54e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CYCS—obesity	2.49e-06	7.44e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GOT1—obesity	2.45e-06	7.3e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GGT1—obesity	2.45e-06	7.3e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—NCOA1—obesity	2.41e-06	7.2e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—STK11—obesity	2.38e-06	7.09e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CYP19A1—obesity	2.38e-06	7.09e-05	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PIK3CD—obesity	2.36e-06	7.03e-05	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—STAT3—obesity	2.35e-06	7.01e-05	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ALB—obesity	2.33e-06	6.94e-05	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—NOS3—obesity	2.22e-06	6.64e-05	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PIK3R1—obesity	2.22e-06	6.64e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—COMT—obesity	2.21e-06	6.59e-05	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MYC—obesity	2.18e-06	6.52e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GNB3—obesity	2.18e-06	6.5e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PPARGC1A—obesity	2.18e-06	6.5e-05	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—TGFB1—obesity	2.18e-06	6.5e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—HMOX1—obesity	2.17e-06	6.47e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GNAS—obesity	2.12e-06	6.33e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—APOB—obesity	2.08e-06	6.2e-05	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PIK3CB—obesity	2.05e-06	6.13e-05	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PTGS2—obesity	2.03e-06	6.07e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—LPL—obesity	1.98e-06	5.92e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GPX1—obesity	1.93e-06	5.77e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CD36—obesity	1.88e-06	5.62e-05	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PIK3CA—obesity	1.85e-06	5.53e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—MTHFR—obesity	1.78e-06	5.33e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PPARA—obesity	1.75e-06	5.23e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—AGT—obesity	1.7e-06	5.06e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—APOE—obesity	1.66e-06	4.96e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CAV1—obesity	1.65e-06	4.92e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—APOA1—obesity	1.64e-06	4.9e-05	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—IL6—obesity	1.64e-06	4.9e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.57e-06	4.7e-05	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—AKT1—obesity	1.51e-06	4.52e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PIK3CG—obesity	1.5e-06	4.48e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PPARG—obesity	1.45e-06	4.32e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—POMC—obesity	1.43e-06	4.26e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—INS—obesity	1.42e-06	4.24e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PIK3CD—obesity	1.32e-06	3.94e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ALB—obesity	1.3e-06	3.89e-05	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PIK3CA—obesity	1.25e-06	3.74e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PIK3R1—obesity	1.24e-06	3.72e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—NOS3—obesity	1.24e-06	3.72e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PIK3CB—obesity	1.15e-06	3.43e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PTGS2—obesity	1.14e-06	3.4e-05	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—AKT1—obesity	1.02e-06	3.05e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PIK3CA—obesity	7e-07	2.09e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—AKT1—obesity	5.72e-07	1.71e-05	CbGpPWpGaD
